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S U M M A R Y
Objectives: Despite the availability of vaccines, children are the people most often affected by epidemic
meningococcal meningitis. The pattern of the epidemic meningococcal meningitis outbreak in Northern
Nigeria in 2009 and the Neisseria meningitidis strains responsible for this epidemic are described here.
Methods: A retrospective cross-sectional study was conducted in 16 states, involving 48 local
government areas (LGAs), 91 health facilities, and 96 communities. Data collection involved in-depth
interviews with key informants from the federal to the community level, a review of records, and a
solution-oriented national workshop with participants from all states of the Federation. Cerebrospinal
ﬂuid (CSF) samples were collected from some of the suspected cases at the start of the outbreak and were
tested using the rapid Pastorex latex agglutination kit.
Results: Kastina (11153, 20.4%), Jigawa (8643, 15.8%), Bauchi (8463, 15.5%), Kano (6811, 12.4%), and
Gombe (6110, 11.2%) were the states with the highest prevalence of meningitis. The states of Nasarawa
(11.0%), Adamawa (8.0%), and Borno (7.6%) recorded the highest percentage of deaths, while the
Shongom (Gombe State 12.5%), Illela (Sokoto State 9.8%), and Ikara (Kaduna State 9.1%) LGAs recorded
the most deaths amongst cases seen.
Conclusions: The testing of CSF samples during meningitis outbreaks is recommended in order to
monitor the occurrence of the multiple meningitis serotypes during these outbreaks and to direct
serotype-speciﬁc vaccination response activities.
 2015 The Authors. Published by Elsevier Ltd on behalf of International Society for Infectious Diseases.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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Epidemic meningococcal meningitis remains a major public
health challenge in Sub-Saharan Africa, despite the availability of
safe and cost-effective vaccines. Each year, approximately
200 000 people, mainly children, are affected by this epidemic.1
Meningococcal meningitis is one of the deadliest diseases that has
been plaguing West Africa for decades. The region that is affected
the most is known as the meningitis belt; the fourteen countries
that encompass the belt are Benin, Burkina Faso, Cameroon, the
Central African Republic, Chad, Coˆte d’Ivoire, the Democratic
Republic of the Congo, Ethiopia, Ghana, Mali, Niger, Nigeria, Togo,
and Senegal.2* Corresponding author.
E-mail address: bassey69@yahoo.com (B.E. Bassey).
http://dx.doi.org/10.1016/j.ijid.2015.12.016
1201-9712/ 2015 The Authors. Published by Elsevier Ltd on behalf of International So
license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Although there are several strains of meningitis, the one that is
most prevalent is meningococcal meningitis.3 In Northern Nigeria,
most meningitis outbreaks have been caused by Neisseria
meningitidis serogroup A.4
Bacterial meningitis can be treated with antibiotics.5 The
climate, poverty, and poor living conditions experienced by the
majority of West Africa’s residents contribute to the severity and
frequency of meningococcal meningitis.6 Epidemics have also been
associated with environmental predictors. The worst outbreak
occurred in 1996–97, affecting over 250 000 people and resulting in
25 000 deaths across the meningitis belt. In 2012, countries in the
belt reported over 11 647 cases including 960 deaths, resulting in a
case fatality rate of 8.2%.7 Overall case fatality rates (CFR) of 6.8% in
2013 and 10.5% in 2014 have been reported in Northern Nigeria.8
This article describes the pattern of the meningococcal
meningitis outbreak in Northern Nigeria in 2009 and identiﬁes
the strains of N. meningitidis responsible for this epidemic.ciety for Infectious Diseases. This is an open access article under the CC BY-NC-ND
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This outbreak was recorded between the ﬁrst and twentieth
epidemiological week of 2009. A suspected case of acute
meningitis was deﬁned in the presence of a fever (>38.5 8C rectal
or 38.0 8C axillary) and a stiff neck (in children >1 year of age) or
bulging fontanelle (in children <1 year of age), with or without
convulsions.9 A conﬁrmed case of acute meningitis was deﬁned as
a suspected case as deﬁned above, with either positive cerebro-
spinal ﬂuid (CSF) antigen detection for bacteria, or a positive CSF
culture for bacterial organisms and/or positive blood culture with
the identiﬁcation of N. meningitidis.9
2.1. Data collection
A retrospective cross-sectional study was conducted in
16 states, involving 48 local government areas (LGAs), 91 health
facilities, and 96 communities. The 16 states were included if at
least one LGA in the state had crossed the alert or epidemic
threshold between weeks 1 and 20 in 2009. In each of the selected
states, three LGAs were selected, two of which had to have been in
the epidemic phase continuously for the highest number of weeks,
and the third LGA had to have been in the alert or non-epidemic
phase between weeks 1 and 20. If a selected state had not had up to
two LGAs in the epidemic phase for at least 2 weeks, then one LGA
in the alert or epidemic phase, one LGA of the state capital, and one
rural LGA were to be included in the evaluation.
In the 16 northern states of Nigeria, the meningitis outbreak
investigation was conducted by the Federal Ministry of Health in
conjunction with World Health Organization (WHO) surveillance
ofﬁcers in all affected states.
Data collection involved in-depth interviews with key infor-
mants from the federal to the community level, a review of the
records, and a solution-oriented national workshop with partici-
pants from all states of the Federation. A total of 64 trained
interviewers (four per state) were involved in data collection. Four
consultants and three WHO staff members supervised the data
collection exercise. At the federal level, key ofﬁcers of the Federal
Ministry of Health, National Primary Health Care Development
Agency, and international partners were interviewed. At the state
level, the Director of Disease Control, a state epidemiologist, a state
immunization ofﬁcer, a state cold chain ofﬁcer, and a health
educator were interviewed. At the health facility level, the head of
the facility, a clinician involved in the management of cases, and
the focal laboratory person were interviewed. Heads of the various
communities were interviewed at the community level.Table 1
Meningitis cases and deaths in 16 northern states of Nigeria, 2009
State Population Cases Percenta
Kastina 6 329 706 11 153 20.4 
Jigawa 4 738 059 8643 15.8 
Bauchi 5 169 866 8463 15.5 
Kano 10 343 660 6811 12.4 
Gombe 2 587 160 6110 11.2 
Zamfara 3 582 912 4656 8.5 
Kaduna 6 629 096 2230 4.1 
Yobe 2 573 989 2032 3.7 
Borno 4 589 174 1694 3.1 
Adamawa 3 451 796 936 1.7 
Sokoto 4 039 811 888 1.6 
Kebbi 3 549 254 493 0.9 
Niger 4 367 029 210 0.4 
Taraba 2 484 694 195 0.4 
Plateau 3 443 202 194 0.4 
Nasarawa 2 036 051 58 0.1 
Total 69 915 459 54 766 CSF samples were collected from some suspected cases at the
start of the outbreak and were tested using the rapid Pastorex latex
agglutination kit. Pastorex test kits were kept in controlled,
refrigerated storage, between 2 and 8 8C. Cold chain procedures
were maintained while transporting test kits to the ﬁeld, using
GioStyle boxes with ice packs. The ﬁeld team conducted quality
control tests on the kits with each usage, and returned the kits to
refrigerated storage at the end of each day.
3. Results
3.1. Meningitis cases and deaths in 16 northern states of Nigeria in
2009
Table 1 shows meningitis cases and deaths seen in 16 northern
states of Nigeria in 2009. A total of 54 766 cases and 2449 deaths
from meningitis were recorded in the 16 states. The states with the
highest prevalence of meningitis included Kastina (11 153, 20.4%),
Jigawa (8643, 15.8%), Bauchi (8463, 15.5%), Kano (6811, 12.4%), and
Gombe (6110, 11.2%). The highest mortality rate for meningitis
was registered in the state of Gombe (13.1 per 100 000), followed
by Kastina (8.5 per 100 000).
3.2. The risk of developing meningitis
The risk of developing meningitis tended to be highest in
Gombe State (236.2 per 100 000 population), followed by Jigawa
State (182.4 per 100 000 population). However, low attack rates
from meningitis were found in the other states located mostly in
the north-central part of Nigeria, including Nasarawa (2.8 per
100 000 population), Niger (4.8 per 100 000 population), Plateau
(5.6 per 100 000 population), and Taraba (7.8 per 100 000 popula-
tion) (Figure 1).
Figure 2 shows the meningitis CFR in 16 northern states of
Nigeria in 2009. A higher proportion of deaths among cases of
cerebrospinal meningitis was found in the states of Nasarawa
(11.0%), Adamawa (8.0%), and Borno (7.6%). However, a low CFR
from meningitis was recorded in Plateau (2.0%) and Taraba (3.0%)
states.
3.3. Meningitis cases and deaths in the 24 most affected LGAs in the
northern states of Nigeria, 2009
Table 2 shows the meningitis cases and deaths seen in the
24 most affected LGAs in the northern part of Nigeria. Among the
affected states, Gombe had the highest number of LGAs affected byge (%) of cases Deaths Mortality rate per 100 000
539 8.5
307 6.5
307 5.9
251 2.4
338 13.1
192 5.4
92 1.4
108 4.2
130 2.8
75 2.2
55 1.4
23 0.6
13 0.3
5 0.2
4 0.1
10 0.5
2449 3.5
Figure 1. Meningitis attack rate in 16 northern states of Nigeria in 2009.
Figure 2. Case fatality rate of meningitis in 16 northern states of Nigeria, 2009.
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found in the three affected LGAs of the state (Yamaltu Deba,
Funakaye, and Shongom). However, some LGAs had only a few
cases of meningitis reported, with less than 1% of cases seen in
Langtang North in Plateau State (0.4%), Tureta in Sokoto State
(0.5%), and Bunza in Kebbi State (0.6%). Also, Yamaltu Deba LGA of
Gombe State, with a high number of cases, recorded the highest
mortality rate of 21.5%, followed by Bayo LGA of Borno State (7.9%).
As shown in Figure 3, the population in Danja LGA of Kastina
State was found to have had the highest risk of developing
meningitis, with 728 cases of meningitis reported per 100 000 pop-
ulation in 2009. However, the risk of developing meningitis was
lower in Bunza LGA of Kebbi State (attack rate 41.3 per
100 000 population) and Langtang North LGA of Plateau State
(attack rate 23.6 per 100 000 population) compared to the other
LGAs.
The CFR of meningitis in the 24 most affected LGAs in the
northern part of Nigeria in 2009 is shown in Figure 4. The LGA withthe highest proportion of deaths among cases seen was Shongom
LGA of Gombe State (12.5%), followed by Illela LGA of Sokoto State
(9.8%) and Ikara LGA of Kaduna State (9.1%). However, Langtang
North LGA of Plateau State recorded no deaths among cases seen in
2009.
Table 3 illustrates the strains of N. meningitidis responsible for
the outbreak in 2009. Out of the 2227 CSF samples tested, 16.8%
were positive for serotype A, while 0.9% were positive for serotype
W135.
4. Discussion
This article describes an outbreak of meningococcal meningitis
due mainly to serotype A in 16 northern states of Nigeria. In this
study, 54 766 cases and 2449 deaths were recorded during the
outbreak in 16 northern states of Nigeria. The number of cases
recorded in this study is ﬁve times higher than the 11 647 recorded
in a similar study in 2012; the number of deaths recorded is two
Figure 3. Meningitis attack rate in the 24 most affected LGAs of the northern states of Nigeria in 2009.
Table 2
Meningitis cases and deaths in the 24 most affected LGAs in Northern Nigeria, 2009
State LGA (District) Population Cases Percentage (%) of cases Deaths Mortality rate per 100 000
Adamawa Guyuk 193 705 150 1.6 7 3.6
Adamawa Shelleng 162 418 230 2.5 21 12.9
Bauchi Damban 166 845 576 6.3 19 11.4
Bauchi Jama’are 130 321 696 7.6 7 5.4
Borno Bayo 87 311 344 3.8 30 34.4
Borno Kwaya Kusar 62 461 172 1.9 13 20.8
Gombe Funakaye 259 484 987 10.8 27 10.4
Gombe Shongom 166 536 88 1.0 11 6.6
Gombe Yamaltu Deba 280 544 1429 15.7 82 29.2
Jigawa Kiyawa 188 397 431 4.7 4 2.1
Jigawa Malam-Maduri 175 867 375 4.1 15 8.5
Kaduna Ikara 211 908 182 2.0 17 8.0
Kaduna Makarﬁ 159 821 141 1.5 3 1.9
Kano Bagwai 179 507 370 4.1 10 5.6
Kano Dambatta 229 244 503 5.5 13 5.7
Kastina Danja 137 359 1000 11.0 22 16.0
Kastina Kankia 165 476 513 5.6 37 22.4
Kebbi Bunza 133 111 55 0.6 4 3.0
Plateau Langtang North 152 345 36 0.4 0 0.0
Sokoto Illela 164 443 122 1.3 12 7.3
Sokoto Tureta 74 710 41 0.5 3 4.0
Yobe Damaturu 97 583 192 2.1 7 7.2
Yobe Nguru 167 008 250 2.7 13 7.8
Zamfara Maru 320 829 227 2.5 5 1.6
Total 4 067 234 9110 100 382 9.4
LGA, local government area.
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in the meningitis belt in 2012.5 In another study, a much lower
number of cases and deaths were recorded in Burkina Faso.18
Health workers in Togo also reported lower numbers of cases.10,11
Overall, this outbreak in Nigeria resulted in a CFR of 4.5. This is
two-fold lower than the CFR of 8.2 reported in 10 countries within
the meningitis belt during an outbreak that occurred between
February and May 2012.5 This is also lower than the CFR of
10.2 reported in Togo.7 Although the period of the outbreak was
similar, the CFRs differ signiﬁcantly probably because the data
under review have come from different countries. Early and
effective management of the cases may also be responsible for the
variation seen in the CFR recorded in these countries.
The present study revealed a cumulative attack rate of 78.3 per
100 000 population; this is far lower than the 517 and 581 per
100 000 reported in Burkina Faso and Togo, respectively.7,11 There
are several potential reasons that could account for the variation inattack rates, the primary reason most likely being household
crowding and active and passive smoking, which are associated
with an increased risk.12 Persons with an antecedent viral infection
are also at increased risk.9 Early studies in the USA demonstrated
that black race and persons of low socioeconomic status were at
higher risk of meningococcal disease than other persons; however,
race and low socioeconomic status are likely markers for
differences in factors such as smoking and household crowding
rather than risk factors.13 During outbreaks, bar or nightclub
patronage and alcohol use have also been associated with a higher
risk of disease.
A high number of cases were observed in the nine states of
Kastina, Jigawa, Bauchi, Kano, Gombe, Zamfara, Kaduna, Yobe, and
Borno. These states reported 11 153, 8643, 8463, 6811, 6110, 4656,
2230, 2032, and 1694 cases, respectively. The cumulative number
of deaths seen in these nine states (n = 2364) is higher than the
960 deaths recorded in a similar outbreak from 42 districts across
Figure 4. Case fatality rate of meningitis in the 24 most affected LGAs in the northern states of Nigeria, 2009.
Table 3
CSF samples received and processed in the state laboratories
State CSF samples Serology
NmA NmC NmW135
Kastina 448 56 - 1
Kano 391 - - -
Kaduna 338 40 - -
Kebbi 183 - - -
Bauchi 174 41 - 1
Yobe 126 - - -
Jigawa 113 84 - -
Borno 93 61 - -
Gombe 92 34 - 1
Adamawa 86 30 - 17
Zamfara 55 - - -
Nasarawa 43 - - -
Sokoto 32 26 - -
Taraba 22 - - -
Niger 19 - - -
Plateau 12 3 - -
Total 2227 375 - 20
CSF, cerebrospinal ﬂuid.
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due to the slow response to the outbreak by the ministries of health
of the various states and to late case detection and investigation, as
well as inadequate case management with the recommended
antibiotics.
The resulting attack rate was very high in 12 of the 16 affected
states, ranging from 13.9 to 236.2 per 100 000 population.
However lower attack rates ranging from 2.8 to 7.8 per
100 000 population were observed in the four states of Nasarawa,
Niger, Plateau, and Taraba. These four states with low attack rates
are located south of the nine states with the highest attack rates.
The high attack rates seen in these nine states may be attributed to
extreme heat accompanied by low humidity, which is a well-
documented predisposing factor in meningitis outbreaks.14 In
these states, the CFR ranged from 2% to 11%, with Plateau State
recording the lowest CFR of 2% and Nasarawa recording the highest
CFR of 11%. The low CFR may be attributed to a prompt response
and effective case management.
The impact of the outbreak on the 24 most affected LGAs was
also evaluated. Yamaltu Deba (Gombe) was the most epidemic
LGA, recording 1429 cases; Danja (Kastina), Funakaye (Gombe),
and Damban (Bauchi) also recorded high numbers of cases: 1000,
987, and 576, respectively. Here the CFR ranged from 0% inLangtang North to 12.5% in Shongom, while the attack rate ranged
from 23.6 per 100 000 in Langtang North to 728 per 100 000 in
Danja.
This suggests that certain factors or conditions within a given
population (not necessarily the size of the population) can lead to
an increase or decrease in the number of cases reported and
hence an increase or decrease in the number of deaths recorded.
Among these factors is a lack of proper awareness of the case
deﬁnition of meningococcal meningitis. The terrain in the north
makes it relatively difﬁcult to access some communities; these
communities would have been successfully reached if the terrain
were different. Poor living and environmental conditions also
contribute to the spread of the bacteria.10 Crowded households
are likely to record more cases than those that are not crowded,
because the bacteria spread through the exchange of respiratory
secretions.9
Because of a lack of proper awareness, the implications and
symptoms of the infection are not always known; therefore cases
may not report to the health facilities for treatment in a timely
manner.15 In addition, the health centers may not be close enough
for easy access by members of the communities.
However, the introduction of the meningococcal serotype A
conjugate vaccine in 2011, targeting persons aged 1–29 years, as
well as enhanced surveillance in Nigeria has since resulted in a
signiﬁcant decline in the number and intensity of outbreaks:
54 766 cases including 2449 deaths were recorded in the 16 states
in 2009 and 1380 cases including 80 deaths were recorded in three
states in 2015.16
N. meningitidis – the causative agent of meningococcal
meningitis – has been separated by seroagglutination into nine
serogroups: A, B, C, D, X, Y, Z, W135, and 29E.17 In this study,
serogroup A (16.8%) and serogroup W135 (0.9%) were responsible
for the outbreak in the 16 northern states in 2009. The major
bacterial strain responsible for most outbreaks in Sub-Saharan
African is serogroup A (NmA). Vigorous testing of CSF samples in
meningitis outbreaks is therefore recommended in order to
monitor the occurrence of the multiple meningitis serotypes
during these outbreaks and to direct serotype-speciﬁc vaccination
response activities.
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